Gene · 6613
Papers2,290
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,290
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| SUMOylation machinery protein, PIAS4 role in breast cancer cell proliferation and drug sensitivity. | Mol Biol Rep | 2026 | 41615552 | PubTator, text mining | PubMed |
| Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma. | J Immunother Cancer | 2026 | 41592893 | PubTator, text mining | PubMed |
| CRISPR/Cas9 library screening uncovered CCT2 as a critical driver of acquired resistance to EGFR-targeted therapy by stabilizing TMX1 in non-small cell lung cancer. | Cell Death Differ | 2026 | 41168408 | PubTator, text mining | PubMed |
| SUMO1 promotes malignancy and chemoresistance in colorectal cancer: Clinical and functional evidence. | Tissue Cell | 2026 | 41129851 | PubTator, text mining | PubMed |
| Catalysis of Native Chemical Ligation and Expressed Protein Ligation by Alkylselenols. | JACS Au | 2025 | 41450653 | PubTator, text mining | PubMed |
| Giant DNA viruses encode a hallmark translation initiation complex of eukaryotic life. | bioRxiv | 2025 | 41256553 | PubTator, text mining | PubMed |
| Druggable Genome-Wide Mendelian Randomization Identifies Distinct Therapeutic Targets for Low Back Pain, Intervertebral Disk Degeneration, and Sciatica. | J Pain Res | 2025 | 41209747 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
| SENP1 drives glycolysis and cisplatin resistance in gastric cancer via desumoylating ENO1. | J Exp Clin Cancer Res | 2025 | 41063235 | PubTator, text mining | PubMed |
| Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma. | Cell Discov | 2025 | 41057295 | PubTator, text mining | PubMed |
| Cooperation between ZEB2 and SP1 upregulates PD‑L1 and CCL2 to promote the immunosuppressive activity of tumor cells. | Int J Oncol | 2025 | 40970322 | PubTator, text mining | PubMed |
| Bimolecular Fluorescence Complementation Assay to Evaluate the Interaction Between SUMO and Its Target Proteins in Cells. | Methods Mol Biol | 2025 | 40875125 | PubTator, text mining | PubMed |
| A Vivo-Morpholino-Based Approach to Block Paralog-Specific SUMOylation. | Methods Mol Biol | 2025 | 40875124 | PubTator, text mining | PubMed |
| Non-Hydrolysable ADP-Ribosylated SUMO2 via Copper(I) Catalyzed Azide Alkyne Cycloaddition. | Methods Mol Biol | 2025 | 40875123 | PubTator, text mining | PubMed |
| Synthesizing Defined Ubiquitin-Modified SUMO Dimers. | Methods Mol Biol | 2025 | 40875116 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
| Identification of SUMOylation modifiers involved in lung adenocarcinoma progression and Osimertinib resistance by integrated bioinformatics analysis. | Sci Rep | 2025 | 40851084 | PubTator, text mining | PubMed |
| Correction to "Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease". | Alzheimers Dement | 2025 | 40847048 | PubTator, text mining | PubMed |
| HDAC6-dependent deacetylation of SAE2 enhances SUMO1 conjugation for mitotic integrity. | EMBO J | 2025 | 40836035 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6613/papers?page=2